Filing Details

Accession Number:
0001209191-21-021301
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-17 16:04:23
Reporting Period:
2021-03-15
Accepted Time:
2021-03-17 16:04:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1723128 Amneal Pharmaceuticals Inc. AMRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1738061 Nikita Shah C/O Amneal Pharmaceuticals, Inc.
400 Crossing Blvd.
Bridgewater NJ 08807
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-03-15 36,330 $2.75 248,251 No 4 M Direct
Class A Common Stock Disposition 2021-03-15 36,330 $6.87 211,921 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy) Disposition 2021-03-15 36,330 $0.00 36,330 $2.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
36,331 2028-05-07 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $6.86 to $6.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The option was granted on May 7, 2018 and the total award of 72,661 vests in four equal installments on May 7, 2019, May 7, 2020, May 7, 2021 and May 7, 2022.